These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 7071071)

  • 1. Saliva-plasma drug concentration ratios during absorption: theoretical considerations and pharmacokinetic implications.
    Posti J
    Pharm Acta Helv; 1982; 57(3):83-92. PubMed ID: 7071071
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug concentrations in plasma and saliva--physiologic and pharmacokinetic considerations].
    Posti J
    Pharm Acta Helv; 1979; 54(7-8):191-6. PubMed ID: 515107
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring of drug concentrations in saliva: a non-invasive pharmacokinetic procedure.
    Ritschel WA; Tompson GA
    Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):511-25. PubMed ID: 6363838
    [No Abstract]   [Full Text] [Related]  

  • 4. [Calculation of different pharmacokinetic parameters from plasma data for a bicompartmental model of first order oral absorption].
    Fredj G; Clenet M; Rousselet F
    Therapie; 1978; 33(1):133-6. PubMed ID: 663893
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors affecting the error in the Loo-Riegelman method for estimating the rate of drug absorption. Some suggestions for a practical sampling schedule.
    Zeng YL; Akkermans AA; Breimer DD
    Arzneimittelforschung; 1983; 33(5):757-60. PubMed ID: 6688184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dependence of salivary drug concentration on salivary flow rate.
    Wood JH; Flora KP; Narasimhachari N; Baker CA
    Methods Find Exp Clin Pharmacol; 1982; 4(4):255-60. PubMed ID: 7121134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance concept in salivary drug excretion. Part I: theory.
    Zuidema J; van Ginneken CA
    Pharm Acta Helv; 1983; 58(3):88-93. PubMed ID: 6844361
    [No Abstract]   [Full Text] [Related]  

  • 8. Methods for estimating drug bioavailability parameters. Part 1: Concept of biological availability and methods for estimating the extent of systemic absorption.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 May; 41(5):313-9. PubMed ID: 3737660
    [No Abstract]   [Full Text] [Related]  

  • 9. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
    Schumacher GE
    Am J Hosp Pharm; 1972 Apr; 29(4):339-43. PubMed ID: 5025265
    [No Abstract]   [Full Text] [Related]  

  • 10. [A pharmacokinetic function for galenics].
    Dost FH
    Arzneimittelforschung; 1971 May; 21(5):712-7. PubMed ID: 5109699
    [No Abstract]   [Full Text] [Related]  

  • 11. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STRIPACT, an interactive curve fit programme for pharmacokinetic analyses.
    Leferink JG; Maes RA
    Arzneimittelforschung; 1979; 29(12):1894-8. PubMed ID: 546430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Statistical considerations in the planning and analysis of pharmacokinetic experiments.
    Westlake WJ
    Acta Pharm Suec; 1974 Dec; 11(6):632. PubMed ID: 1136784
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug content study of human saliva, bile and cerebrospinal fluid].
    Scherber A; Feller K; Terhaag B; Le Petit G; Richter K
    Farmakol Toksikol; 1982; 45(5):106-7. PubMed ID: 7140946
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on absorption and elimination of drugs. Part VII. Fitting of a three exponential equation to the observed drug concentration data after single extravascular administration.
    Danek A; Kajzar F; Zieba A
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):86-94. PubMed ID: 631975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated pharmacokinetic-dynamic modeling of drugs acting on the CNS.
    Paalzow LK
    Drug Metab Rev; 1984; 15(1-2):383-400. PubMed ID: 6378561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small animal model utilizing salivary drug excretion for pharmacokinetic determinations.
    Piraino AJ; DiGregorio GJ; Ruch EK
    J Pharmacol Methods; 1980 Jan; 3(1):1-7. PubMed ID: 7374168
    [No Abstract]   [Full Text] [Related]  

  • 18. [An electronic simulator for demonstration of pharmacokinetic concentration patterns].
    Bättig P
    Arzneimittelforschung; 1972 Mar; 22(3):603-6. PubMed ID: 5067940
    [No Abstract]   [Full Text] [Related]  

  • 19. An APL computer program for estimating rate constants of drug absorption.
    Zeng YL; Akkermans AA; van Waning WE; Breimer DD
    Arzneimittelforschung; 1983; 33(6):902-4. PubMed ID: 6688530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for estimating drug bioavailability parameters. Part 2: Methods for estimating absorption rate.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 Jun; 41(6):369-77. PubMed ID: 3763679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.